IRCSS Policlinico San Matteo

Pavia 27100

0 studies enrolling now · 3 studies all time

What they study most

Anaplastic Large-Cell Lymphoma, Diffuse Large B-cell Lymphoma Refractory, Follicular B-cell Non-Hodgkin's Lymphoma, HER2 Positive Breast Cancer, Non-Hodgkin Lymphoma, T-Cell Lymphoma

Studies at this site

• A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer — Completed
• ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas — Completed
• Study of Rituximab and Bendamustine With or Without Brentuximab Vedotin for CD30 Positive Diffuse Large B-cell Lymphoma — Stopped early